Influence of nicorandil on levels of hsCRP ,sCD40L and therapeutic effect of nicorandil in patients with microvascular angina pectoris
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3969/j.issn.1008-0074.2018.03.16
   		
        
        	
        		- VernacularTitle:尼可地尔对微血管性心绞痛患者hsCRP、sCD40L水平的影响及临床疗效
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Bin CHEN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Hua LIU
			        		
			        		;
		        		
		        		
		        		
			        		Yong-Jun ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Zhi-Hui MA
			        		
			        		;
		        		
		        		
		        		
			        		Jian-Ping TAO
			        		
			        		;
		        		
		        		
		        		
			        		Yu HU
			        		
			        		;
		        		
		        		
		        		
			        		Jin-Mei ZENG
			        		
			        		;
		        		
		        		
		        		
			        		Xing-De WANG
			        		
			        		;
		        		
		        		
		        		
			        		Zhong CHEN
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 上海市第六人民医院心内科
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Microvacular angina;
			        		
			        		
			        		
				        		C-reactive protein;
			        		
			        		
			        		
				        		CD40 ligand;
			        		
			        		
			        		
				        		Nicorandil
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of cardiovascular Rehabilitation Medicine
	            		
	            		 2018;27(3):296-299
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective :To explore influence of nicorandil on plasma levels of high sensitive C reactive protein (hsCRP) and soluble T cell CD40 ligand (sCD40L) and therapeutic effect of nicorandil in patients with microvascular angina pectoris .Methods :A total of 102 patients with microvascular angina pectoris were enrolled ,randomly and equally divided into routine treatment group (received routine comprehensive treatment ) and nicorandil group (received nic-orandil based on routine comprehensive treatment ,5mg ,3 times/d) ,both groups were treated for eight weeks . Plasma levels of hsCRP and sCD40L were measured and compared between two groups before and eight weeks after treatment ,and therapeutic effect was compared between two groups .Results : Compared with before treatment there were significant reductions in plasma levels of hsCRP and sCD 40L in both groups after eight weeks ;compared with routine treatment group after treatment ,there were significant reductions in plasma levels of hsCRP [ (2.63 ± 0.25) mg/L vs.(1.80 ± 0.28) mg/L] and sCD40L [ (71.88 ± 3.71) pg/ml vs .(55.25 ± 2.47) pg/ml] in nicorandil group , P=0. 001 all.Total effective rate of nicorandil group was significantly higher than that of routine treatment group (78.43% vs.56.86%,P=0.02).Conclusion :Nicorandil can significantly rise clinical effect ,reduce plasma levels of hsCRP and sCD40L in patients with microvascular angina pectoris .